Anamorelin
- Generic Name
- Anamorelin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C31H42N6O3
- CAS Number
- 249921-19-5
- Unique Ingredient Identifier
- DD5RBA1NKF
- Indication
Investigated for use/treatment in cachexia and anorexia.
- Associated Conditions
- -
- Associated Therapies
- -
On the cusp of targeted therapy for cancer cachexia — what clinical benefits might we ...
Studies highlight diagnostic criteria for cancer cachexia, adverse effects of systemic cancer therapy on skeletal muscle, and management guidelines, including randomized trials of treatments like olanzapine and anamorelin.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath